3
Announcements
Trials
Browse
Landscape
Status
Recruiting
2
Completed
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Neoplasms
24
Breast Neoplasms
11
Prostatic Neoplasms
10
Colorectal Neoplasms
10
Hematologic Neoplasms
7
Ovarian Neoplasms
6
Lung Neoplasms
5
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Multiple Myeloma
4
Advanced Cancer
4
Uterine Cervical Neoplasms
3
Rectal Neoplasms
3
Lymphoma
3
Head and Neck Neoplasms
3
Gastrointestinal Neoplasms
3
Sarcoma
2
Peritoneal Neoplasms
2
Pain
2
Neoplasm Metastasis
2
Mouth Neoplasms
2
Melanoma
2
Low Anterior Resection Syndrome
2
Hematopoietic and Lymphoid System Neoplasm
2
Fatigue
2
Endometrial Neoplasms
2
Depression
2
Colorectal Neoplasms, Hereditary Nonpolyposis
2
Colonic Neoplasms
2
Brain Neoplasms
2
Bone Neoplasms
2
Interventions
Gemcitabine
78
Cisplatin
55
pembrolizumab
31
Paclitaxel
28
Carboplatin
24
Docetaxel
19
Radiotherapy
17
Mitomycin
16
Doxorubicin
15
atezolizumab
14
BCG Vaccine
14
Nivolumab
13
Cystectomy
12
Filgrastim
11
vinflunine
10
Methotrexate
10
Vinblastine
9
Fluorouracil
9
5-aminolevulinic acid hexyl ester
9
Sunitinib
7
Early Intervention, Educational
7
durvalumab
6
avelumab
6
Taxes
6
Methods
6
Cystoscopy
6
Albumin-Bound Paclitaxel
6
enfortumab vedotin
5
Trastuzumab
5
Surveys and Questionnaires
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Urinary Bladder Neoplasms
×
Interviews as Topic
×
Clear all
NCT04334226
2021-03-04
StomABC Impact
University of Kansas Medical Center
Completed
16 enrolled